FX-FY11-ocme-forensic drug standard

This contract opportunity, identified by the unique ID 66c85f8a829eb5d869076062, is a procurement initiative issued by the District of Columbia for forensic drug standards, specifically designated for DCSS (District of Columbia Shared Services). The procurement was originally posted on November 22, 2010, with a proposal submission deadline of December 9, 2010. While specific details about the exact scope of work are limited, the contract appears to be focused on acquiring forensic drug testing standards, likely for scientific or laboratory purposes within the District's government. The procurement seems targeted at specialized scientific or medical supply vendors with expertise in forensic drug testing materials and standards. The short timeline between posting and submission suggests this was a potentially urgent or time-sensitive procurement need for the District's Office of the Chief Medical Examiner (OCME) or a related forensic science department.

Given the limited information provided, it is challenging to definitively state set-aside designations or specific vendor restrictions. The procurement does not explicitly indicate preferences for disadvantaged business enterprises or small business participation. No incumbent vendors or current contractors are mentioned in the available documentation. The contract does not specify a clear budget range or potential award value. The procurement appears to be specifically restricted to DCSS, which may indicate internal sourcing preferences or limitations on vendor eligibility. Without additional context, the potential vendor pool seems to be specialized scientific or medical supply firms with demonstrated capabilities in forensic drug testing standard production and distribution.